Project REVEAL-ACS – IIR, VDO031 (D1BVXAL02800), Geisler

Basic data

Acronym:
REVEAL-ACS
Title:
IIR, VDO031 (D1BVXAL02800), Geisler
Duration:
17/12/2015 to 31/12/2017
Abstract / short description:
Interventionelle "investigator initiated research" klinische Studie (IIR) zur Untersuchung des Effekts von Rivaroxaban auf Plättchenfunktion, Plättchen-vermittelte Gefäßentzündung, insbesodere auf die Thrombinerzeugung und deren intrazelluläre Mechanismen, bei ACS-Patienten verglichen mit der standard dualen antiplatelet Therapie (DAPT) ex vivo (Teil 1) und in vivo (Teil 2)
Keywords:
ACS
dual antiplatelet therapy
rivaroxaban
NSTEMI
platelet function
thrombin

Involved staff

Managers

Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Internal Medicine Department III
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine

Funders

Leverkusen, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.